Fundraising Fox
Emulate Bio
Founded 2014 · 73 employees on LinkedIn · 11 known investors
Find your way into Emulate Bio
Each arrow is one introduction. Sign up to fill in the first one.
Ask Kent Wakeford to introduce you to Donald Ingber
You →Kent · together at Breaking →Donald
Ask Jamie Chen to introduce you to Lorna Ewart
You →Jamie · together at AstraZeneca →Lorna
Ask Sam Okafor to introduce you to Jim Corbett
You →Sam · together at ViaCell, Inc. →Jim
Sign up to find every way you can get introduced to Emulate Bio
- Your email: who you already know at Emulate Bio, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Emulate Bio team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Emulate builds Organ-on-a-Chip systems, including platforms, consumables, and pre-assembled BioKits with validated human cell models, to support drug discovery research. It serves life sciences and pharmaceutical researchers and provides installation, training, and validated protocols for Organ-Chip experiments.
Founders & leadership
Emulate Bio was founded in 2014 by Donald Ingber and Daniel Levner.
Investors · 11
How we know: the company's own site · Not right? Tell us
How we know: the company's own site · Not right? Tell us
How we know: ALS Investment Fund's portfolio page · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: av.vc · Not right? Tell us
How we know: Fourth Realm's portfolio page · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: Stray Dog Capital's portfolio page · the VCSheet dataset · Not right? Tell us
How we know: open dataset · 5k.vc investor directory · Not right? Tell us
How we know: the VCSheet dataset · Not right? Tell us
How we know: the VCSheet dataset · Not right? Tell us
Non-dilutive funding · 1 SBIR/STTR award
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2018 | $150K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- What does Emulate Bio do?
- Emulate builds Organ-on-a-Chip systems, including platforms, consumables, and pre-assembled BioKits with validated human cell models, to support drug discovery research. It serves life sciences and pharmaceutical researchers and provides installation, training, and validated protocols for Organ-Chip experiments.
- Who founded Emulate Bio?
- Emulate Bio was founded by Donald Ingber, Daniel Levner in 2014.
- Who are Emulate Bio's investors?
- Emulate Bio's investors include +ND Capital, Northpond Ventures, ALS Investment Fund, Alumni Ventures, Alwyn Capital, Fourth Realm, Stray Dog Capital, VegInvest and 3 more.